Reuters logo
BRIEF-U.S. FDA grants fast track designation for Amicus Therapeutics’ migalastat for treatment of Fabry disease
September 19, 2017 / 11:41 AM / in a month

BRIEF-U.S. FDA grants fast track designation for Amicus Therapeutics’ migalastat for treatment of Fabry disease

Sept 19 (Reuters) - Amicus Therapeutics Inc

* U.S. FDA grants fast track designation for Amicus Therapeutics’ migalastat for treatment of Fabry disease

* Amicus Therapeutics Inc - ‍company plans to submit a new drug application (NDA) for migalastat in Q4 of 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below